下腔静脉滤器对髂腔静脉支架结局的影响
一项回顾性研究比较了存在下腔静脉滤器的患者与无滤器匹配队列接受髂腔静脉支架的结局。滤器组术后深静脉血栓发生率更高(10% vs 3%,P=0.03),因支架内再狭窄行再干预率更高(16% vs 4%,P=0.006),但支架通畅率无显著差异。
要点
- 髂腔静脉支架患者若存在下腔静脉滤器,同侧深静脉血栓风险增加。
- 滤器组因支架内再狭窄再干预率显著高于对照组(16% vs 4%)。
- 滤器移除指征消失后应尽早移除,以降低血栓和再干预风险。
核心结论
- 合并下腔静脉滤器的髂腔静脉支架患者深静脉血栓发生率更高,因支架内再狭窄再干预率也更高。
- 应尽可能在滤器不再需要时尽早移除下腔静脉滤器。
研究设计与样本
- 回顾性研究,纳入2000至2015年15年间初次放置髂腔静脉支架的患者。
- 滤器组50条肢体(40例患者),对照组为同期无滤器的匹配队列156条肢体(155例患者)。
主要发现
- 中位随访43个月(滤器组)和40个月(对照组),两组VCSS和VAS疼痛评分在12个月时均显著改善,组间无显著差异(P>0.05)。
- 滤器组深静脉血栓发生率为10%,对照组为3%,差异有统计学意义(P=0.03)。
- 48个月时,滤器组与对照组的一期通畅率分别为64%和65%(P=0.6),一期辅助通畅率分别为100%和97%(P=0.5),二期通畅率分别为100%和75%(P=0.4)。
- 滤器组因支架内再狭窄再干预率为16%,对照组为4%,差异有统计学意义(P=0.006)。
临床怎么用
- 对存在下腔静脉滤器且需行髂腔静脉支架的患者,应警惕术后深静脉血栓和支架内再狭窄风险。
- 滤器临床指征一旦解除,应尽早移除下腔静脉滤器。
局限性
- 回顾性研究设计,样本量有限,可能存在选择偏倚。
- 滤器组与对照组基线特征未全面报告,匹配方法未详细说明。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The impact of presence of an IVC filter in patients undergoing stenting for symptomatic femoroiliocaval obstruction has not been explored in detail. This study attempts to fill this gap by evaluating clinical and stent-related outcomes in such patients. The incidence of deep vein thrombosis (DVT) in this setting is also analyzed. METHODS: A retrospective review of contemporaneously entered EMR data on initial iliocaval stents placed in patients with an indwelling IVC filter (or placed after stenting) over a 15-year period from 2000 to 2015 was performed. A separate matched cohort that underwent initial stenting during the time frame, but which did not have an IVC filter, was utilized as the control group. Clinical outcomes were evaluated through use of the venous clinical severity score (VCSS) and visual analog scale (VAS) pain scores. Incidence of deep venous thrombosis after stenting was also reviewed in both groups. The Kaplan-Meier analysis was used to assess stent patency after intervention while t-tests were used to examine preintervention and postintervention outcomes within and in-between groups. RESULTS: A total of 50 limbs (40 patients) underwent placement of a femoroiliocaval stent in the setting of a preexisting (49) or post-stent (1) IVC filter [filter group]. The control group had 156 limbs (155 patients). There was no difference in VCSS, VAS pain score, or grade of swelling at baseline between the 2 groups. Over the median follow-up duration (43 months-filter group; 40 months-control group), VCSS went from 6 to 4 at 12 months (P = 0.0001) in the filter group and from 6 to 4 in the control group (P < 0.0001). VAS pain scores went from 7 to 0 at 12 months (P < 0.0001) in the filter group and from 5 to 0 in the control group (P < 0.0001). There was no significant difference in the VCSS scores or VAS pain score between the 2 groups at 12 months (P > 0.05). Overall, there was a statistically significant increase in the incidence of DVT in the filter group (10%) compared to the control group (3%) [P = 0.03%]. Primary, primary assisted, and secondary patencies in the filter/control groups at 48 months were 64%/65% (P = 0.6), 100%/97% (P = 0.5), and 100%/75% (P = 0.4), respectively. Reintervention from in-stent restenosis was noted in 16% of patients in the filter group compared to 4% in the control group (P = 0.006). CONCLUSIONS: Patients with an IVC filter in the setting of a femoroiliocaval stent tend to have an increased rate of deep venous thrombosis on the stented side. In addition, an increased rate of reintervention secondary to in-stent restenosis was also noted. In light of this, every attempt should be made to remove the IVC filter as soon as the need for the filter no longer exists.
引用
- Jayaraj A, Noel C, Raju S, et al. Impact of Presence of Inferior Vena Cava Filter on Iliocaval Stent Outcomes. Ann Vasc Surg. 2020. PMID: 32278870. doi:10.1016/j.avsg.2020.03.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。